JP2014501929A - 診断方法 - Google Patents

診断方法 Download PDF

Info

Publication number
JP2014501929A
JP2014501929A JP2013547903A JP2013547903A JP2014501929A JP 2014501929 A JP2014501929 A JP 2014501929A JP 2013547903 A JP2013547903 A JP 2013547903A JP 2013547903 A JP2013547903 A JP 2013547903A JP 2014501929 A JP2014501929 A JP 2014501929A
Authority
JP
Japan
Prior art keywords
cells
mcm
bladder cancer
sample
threshold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013547903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501929A5 (enExample
Inventor
ギャロウェイ，デイビッド
コールマン，ニック
Original Assignee
サイトシステムズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイトシステムズ リミテッド filed Critical サイトシステムズ リミテッド
Publication of JP2014501929A publication Critical patent/JP2014501929A/ja
Publication of JP2014501929A5 publication Critical patent/JP2014501929A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G01N33/575—
    • G01N33/57557—
    • G01N33/5759—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
JP2013547903A 2011-01-07 2012-01-06 診断方法 Pending JP2014501929A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1100223.5 2011-01-07
GBGB1100223.5A GB201100223D0 (en) 2011-01-07 2011-01-07 Diagnostic method
PCT/GB2012/000008 WO2012093251A1 (en) 2011-01-07 2012-01-06 Diagnostic method

Publications (2)

Publication Number Publication Date
JP2014501929A true JP2014501929A (ja) 2014-01-23
JP2014501929A5 JP2014501929A5 (enExample) 2015-11-12

Family

ID=43663908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013547903A Pending JP2014501929A (ja) 2011-01-07 2012-01-06 診断方法

Country Status (8)

Country Link
US (1) US10107814B2 (enExample)
EP (2) EP3214445B1 (enExample)
JP (1) JP2014501929A (enExample)
AU (1) AU2012204796A1 (enExample)
CA (1) CA2823460A1 (enExample)
GB (1) GB201100223D0 (enExample)
IL (1) IL227295A0 (enExample)
WO (1) WO2012093251A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023527557A (ja) * 2020-05-28 2023-06-29 サイトベイ インコーポレイテッド 細胞病理染色

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11054426B2 (en) * 2011-01-07 2021-07-06 Cytosystems Ltd Diagnostic method
US11519916B2 (en) 2015-06-08 2022-12-06 Arquer Diagnostics Limited Methods for analysing a urine sample
EP4060344A1 (en) 2015-06-08 2022-09-21 Arquer Diagnostics Limited Methods and kits
GB201511196D0 (en) 2015-06-25 2015-08-12 Cytosystems Ltd Monoclonal antibodies
EP4217746A1 (en) * 2020-09-24 2023-08-02 Cytosystems Limited Diagnosis of cancer by imaging flow cytometry

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
WO2006116327A1 (en) * 2005-04-21 2006-11-02 California Institute Of Technology Uses of parylene membrane filters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5014003068; Ｓｔｏｅｂｅｒ　Ｋ，外１１名: 'Ｄｉａｇｎｏｓｉｓ　ｏｆ　ｇｅｎｉｔｏ-ｕｒｉｎａｒｙ　ｔｒａｃｔ　ｃａｎｃｅｒ　ｂｙ　ｄｅｔｅｃｔｉｏｎ　ｏｆ　ｍｉｎｉｃｈｒｏｍｏｓｏｍｅ　ｍａｉｎｔｅｎａｎｃｅ　５　ｐｒｏｔｅｉｎ　ｉｎ　ｕｒｉ' Ｊ　Ｎａｔｌ　Ｃａｎｃｅｒ　Ｉｎｓｔ． Ｖｏｌ．９４，Ｎｏ．１４, 20020717, Ｐａｇｅ．１０７１-１０７９ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023527557A (ja) * 2020-05-28 2023-06-29 サイトベイ インコーポレイテッド 細胞病理染色
JP7540010B2 (ja) 2020-05-28 2024-08-26 サイトベイ インコーポレイテッド 細胞病理染色

Also Published As

Publication number Publication date
CA2823460A1 (en) 2012-07-12
EP3214445B1 (en) 2018-11-14
EP2661628B1 (en) 2016-12-21
AU2012204796A1 (en) 2013-08-01
EP2661628A1 (en) 2013-11-13
GB201100223D0 (en) 2011-02-23
IL227295A0 (en) 2013-09-30
US10107814B2 (en) 2018-10-23
WO2012093251A1 (en) 2012-07-12
EP3214445A1 (en) 2017-09-06
US20130059930A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
EP2425253B1 (en) New antibody cocktail
JP5221381B2 (ja) 卵巣癌を判定するためのｈｅ４及び他の生化学マーカーの使用
HUP0004134A2 (en) Determination of cellular growth abnormality
US10107814B2 (en) Diagnostic method
JP5754844B2 (ja) 泌尿器科がんの検査方法及び検査用キット
JP5727931B2 (ja) アッセイ
US11054426B2 (en) Diagnostic method
US20220381785A1 (en) Cancer Detection Method
JP5280214B2 (ja) 炎症性腸疾患の診断方法
Partyka et al. Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification
JP6685229B2 (ja) 癌を検出する方法
JP5574522B2 (ja) 癌マーカー及び癌細胞の検査方法
US20230176061A1 (en) Methods for diagnosing high-risk cancer using polysialic acid and one or more tissue-specific biomarkers
CN111208304A (zh) 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150916

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20151007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151009

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160309

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160610